Issue 1,577: July 7, 2021
|
|
|
|
|
Top Stories |
|
- "Use of mRNA COVID-19 Vaccine after Reports of Myocarditis among Vaccine Recipients: Update from
the Advisory Committee on Immunization Practices—United States, June 2021" published in MMWR Early
Release
- Introducing the next chapter in IAC’s leadership: Kelly L. Moore, MD, MPH
- CDC offers resources to help get the word out about catching children up on routine vaccinations
- CDC and WhatsApp, a multiplatform messaging app, launch “Mi Chat Sobre Vacunas COVID” to help Spanish-speaking
communities find information about vaccine locations and get answers to frequently asked questions
- Order IAC’s free, CDC-supported “Me Vacuné Contra el COVID-19” buttons and stickers to encourage vaccination
in Latinx communities. Also available in English.
- HHS’s COVID-19 Community Corps adds COVID-19 toolkits for LGBTQ+ community, people with disabilities, and faith-based leaders
(also available in Spanish) to its library of resources
- American Pharmacists Association offers “Vaccine Confident” program to foster communication and understanding about
COVID-19 vaccines
- Voices for Vaccines releases new podcast on vaccines and health equity with health equity expert Nate Chomilo, MD, FAAP
- Johns Hopkins' campaign, "Get the Facts about the Vax," helps people make informed decisions about COVID-19
vaccine
- IAC Spotlight! These updated IAC educational materials and web pages were released during May and June
- Don’t let your colleagues be the last to know. Urge them to subscribe to IAC Express for free.
- IAC experts called on by news media
- Not-to-miss immunization articles in the news
IAC Handouts
Featured Resources
Journal Articles and Newsletters
Immunization PSAs from the Archive
Top Stories
“Use of mRNA COVID-19 Vaccine after Reports of
Myocarditis among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices—United States, June 2021”
published in MMWR Early Release
CDC published Use of mRNA COVID-19 Vaccine after Reports of Myocarditis among Vaccine Recipients: Update from the Advisory
Committee on Immunization Practices—United States, June 2021 in the July 6 issue of MMWR Early Release. A portion of the
summary appears below.
An elevated risk for myocarditis among mRNA COVID-19 vaccinees has been observed, particularly in males aged 12–29
years....
...On June 23, 2021, the Advisory Committee on Immunization Practices concluded that the benefits of COVID-19 vaccination to individual
persons and at the population level clearly outweighed the risks of myocarditis after vaccination....
...Continued use of mRNA COVID-19 vaccines in all recommended age groups will prevent morbidity and mortality from COVID-19 that far
exceed the number of cases of myocarditis expected. Information regarding the risk for myocarditis with mRNA COVID-19 vaccines should be
disseminated to providers to share with vaccine recipients.
Access the MMWR Early Release article in HTML format or in PDF format.
Related Link
Back to top
Introducing the next chapter in
IAC’s leadership: Kelly L. Moore, MD, MPH
On July 1, 2021, IAC founder and executive director Deborah L. Wexler, MD, turned over the leadership of IAC to Kelly L. Moore, MD, MPH. We
welcome Kelly to the helm of IAC in our IAC Express Special Edition article, Introducing the Next Chapter in IAC's Immunization
Leadership.
Joining Kelly are six new board members of diverse and distinguished backgrounds: Carolyn W. Schott (chair), Clement Lewin (treasurer), Kathryn M.
Edwards, Elisa Greene, Patricia B. Hairston, and Jamie Swift. Learn more about our new directors at the Board of
Directors web page.
Back to top
CDC offers resources to help get the
word out about catching children up on routine vaccinations
The pandemic disrupted routine well-child visits, leading to a decline in routine childhood vaccines. Fall is right around
the corner and many children returning to schools, camps, playdates, and daycares are behind on their vaccines. The CDC offers
resources to help catch children up on missed routine childhood
vaccines. Resources include:
Related Link
Back to top
CDC and WhatsApp, a multiplatform
messaging app, launch “Mi Chat Sobre Vacunas COVID” to help Spanish-speaking communities find information about vaccine locations
and get answers to frequently asked questions
The CDC and WhatsApp, a multiplatform messaging app, launched Mi Chat
Sobre Vacunas COVID to increase vaccination rates among Latinx Americans. Users can message (833) 636-1122 from their app and
receive information about nearby vaccination locations, arrange a free ride to get vaccinated, and get answers to frequently asked questions from the
CDC helpline.
Related Links
Back to top
Order IAC’s free, CDC-supported “Me Vacuné Contra el COVID-19” buttons and
stickers to encourage vaccination in Latinx communities. Also available in English.
Public health departments, nonprofit organizations, and all clinics that provide vaccination services in communities experiencing health disparities or
vaccine hesitancy can order IAC’s FREE
I Got My COVID-19 Vaccine buttons and stickers, provided with support from CDC. Spanish-language
buttons and stickers are cheerful, highly visible tools to help you communicate the importance of COVID-19 vaccination in Latinx communities. Access this order
form to request the FREE buttons and stickers in Spanish and English for your outreach efforts.
Buttons and stickers remain available for sale to those not eligible for the CDC-funded supplies.
Related Links
Back to top
HHS’s COVID-19 Community
Corps adds COVID-19 toolkits for LGBTQ+ community, people with disabilities, and faith-based leaders (also available in Spanish) to its library of
resources
The U.S. Department of Health and Human Services' (HHS) national campaign We Can Do This aims to increase uptake of COVID-19 vaccines while reinforcing basic
prevention measures such as mask-wearing and social distancing. Through a nationwide network of trusted messengers and consistent, fact-based
messaging, the campaign helps people make informed decisions about their health and COVID-19. The effort is driven by communication science and
provides tailored information for at-risk groups.
"We Can Do This" recently added toolkits for
LGBTQ+ Community,
People with Disabilities,
Faith-Based Leaders, and
Faith-Based Leaders – Spanish under the Resources
and Toolkits tab on
wecandothis.hhs.gov.
HHS invites you to join the
COVID-19 Community Corps. As a member, you’ll receive timely, accurate information to share with your family, friends,
and neighbors. By encouraging them to get vaccinated, you’ll help protect them and allow all of us to safely gather again. As a Corps member,
you’ll get resources to help you build vaccine confidence in your community.
Join
the COVID-19 Community Corps at no cost.
Related Links
Back to top
American Pharmacists Association
offers “Vaccine Confident” program to foster communication and understanding about COVID-19 vaccines
The American Pharmacists
Association (APhA) is collaborating with the CDC on
Vaccine Confident, a multifaceted project that leverages pharmacists’ accessibility and trusting
relationships with patients to promote confidence in the COVID-19 vaccines. Resources available include:
- A broad array of practice resources to keep pharmacists informed about COVID-19 vaccine developments and
help pharmacists engage patients who have questions. These include fact sheets, toolkits, playbooks, and other resources.
- Continuing pharmacy education (CPE) programs covering core topics a pharmacist needs to know about this fast-changing
disease
- Public-oriented materials with science-based, unbiased
information about the vaccines in
multiple languages, including vaccine development, administration, effectiveness, side effects, and benefits
- Dozens of short videos for social media, showing pharmacists discussing why they got vaccinated, why they recommend
COVID-19 vaccines to their patients, and how they respond to their patients’ questions and concerns
- A series of
success stories as pharmacists discuss vaccine issues with their patients
APhA conducts national surveys regularly to monitor vaccine
confidence trends among pharmacists and pharmacy team members. Recently, 92% of the respondents said they planned to be or have been
vaccinated and 98% said they were comfortable addressing vaccine concerns.
Back to top
Voices for Vaccines releases new podcast on vaccines
and health equity with health equity expert Nate Chomilo, MD, FAAP
Voices for Vaccines (VFV) has posted a new entry in its Vax Talk podcast series:
What Is
Health Equity, and What Does It Have to Do with Vaccines? A description from their web page appears below.
With the pandemic bringing a bright spotlight on vaccine hesitancy, people are under the impression that confidence varies by race and
background. Why would that be, and how is it related to health equity? And what is health equity anyhow?
We invited University of Minnesota School of Medicine professor and health equity expert Dr. Nate Chomilo to our podcast to ask him all the questions
about health equity we could think of and to drill down about vaccine equity, as well.
Voices for Vaccines is a national organization of parents and others who are dedicated to raising the level of the voices of immunization supporters.
VFV invites everyone who values vaccines to become a member, use VFV tools in their own community, and sign up for
VFV’s free newsletter. Please spread the word to your friends and colleagues to join VFV!
Related Links
Back to top
Johns Hopkins' campaign,
"Get the Facts about the Vax," helps people make informed decisions about COVID-19 vaccine
Johns Hopkins Center for Communications Programs' campaign
Get the Facts about the Vax offers easily digestible and trustworthy information on the COVID-19 vaccines.
The campaign materials are publicly accessible, providing accurate and research-driven information that can help people make an informed decision
about getting vaccinated.
To learn more about the "Get the Facts about the Vax" campaign and to access the campaign toolkit materials, visit www.vaxfacts.jhu.edu.
Related Links
Back to top
IAC Spotlight! These updated IAC educational materials and web pages were
released during May and June
IAC Express regularly provides readers with information about IAC’s new and updated educational materials for healthcare
professionals and handouts for patients. All IAC materials are free to distribute.
In case you missed them during recent weeks, these helpful materials were announced:
IAC’s Updated Materials for Clinicians
Updated COVID-19 Web Pages
Related Links
Back to top
Don’t let your colleagues be
the last to know. Urge them to subscribe to IAC Express for free.
Dive into summer with hot-off-the-press, weekly immunization information at your fingertips! IAC Express, the free weekly e-newsletter
produced by the Immunization Action Coalition (IAC), succinctly summarizes the week’s important immunization developments, including new and
updated vaccine recommendations from CDC and the latest vaccine decisions by FDA. IAC Express also contains newly posted Vaccine
Information Statements and their translations, and immunization education materials from IAC, CDC, AAP, and others. Subscribers learn about online and
in-person educational opportunities, many offering free continuing education credit.
We appreciate you as a subscriber! Encourage your co-workers to subscribe to IAC Express so they get everything that matters to
vaccinators in their own inbox.
Back to top
IAC experts called on by news
media
Journalists seek out IAC experts to help explain vaccines to the public and policy makers. Our goal is to help the media understand and communicate
the complex work vaccinators do. Here is a recent citation:
Related Link
Back to top
Not-to-miss immunization articles in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Back to top
IAC Handouts
IAC updates "Notification of Vaccination Letter Template"
IAC recently revised its Notification of Vaccination Letter Template. Revisions include the addition of COVID-19, MenQuadfi, and Vaxelis vaccines and the
removal of Zostavax.
Related Links
Back to top
IAC updates both the child and adult
versions of 2-page reference table, “Guide to Contraindications and Precautions to Commonly Used Vaccines”
IAC recently revised Guide to Contraindications and Precautions to Commonly Used Vaccines as well as Guide to
Contraindications and Precautions to Commonly Used Vaccines in Adults to highlight a link to find contraindications and precautions for COVID-19
vaccines and to remove references to zoster vaccine live (ZVL) from the table.
Related Links
Back to top
Featured Resources
United States Pharmacopeia releases
updated version of its “COVID-19 Vaccine Handling Toolkit” with operational considerations for healthcare
personnel
In June, the United States Pharmacopeia (USP) released version 4.0 of its
COVID-19 Vaccine Handling Toolkit. The revisions include:
- Extended storage time for undiluted, thawed Pfizer-BioNTech vaccine vials
- Considerations for maximizing doses withdrawn from larger-size Moderna vials
- Revised beyond-use date information (12 hours after vial puncture) for the Moderna vaccine
The toolkit also includes updated Moderna and Pfizer-BioNTech guides to help safely and consistently maximize doses withdrawn from a vial and to
address operational efficiency gaps in handling COVID-19 vaccines.
You can complete the form for immediate access to the toolkit and supporting resources.
Related Links
Back to top
NFID’s “Keep Up the Rates” campaign is expanding to address coadministration of
COVID-19 vaccines with other vaccines, as well as health equity
The National Foundation for Infectious Diseases (NFID) launched a national campaign, Keep Up the Rates, to encourage all individuals to receive recommended vaccines
that may have been delayed during the pandemic. The multimedia campaign engages national experts and leading public health organizations to reach
populations most at risk of delaying vaccination or experiencing complications from vaccine-preventable diseases.
The focus of the campaign is now expanding to address the coadministration of COVID-19 vaccines with other vaccines, as well as health equity and
disparities in health outcomes.
Related Links
Back to top
Journal Articles and Newsletters
“Safety of Vaccines Used for
Routine Immunization in the United States: An Updated Systematic Review and Meta-Analysis” published in
Vaccine
In the June 23 issue, Vaccine published Safety of Vaccines Used for Routine Immunization in the United States:
An Updated Systematic Review and Meta-Analysis. A portion of the abstract appears below.
...Our objective was to conduct a systematic review of the safety of vaccines recommended for children, adults, and pregnant women in the United
States....
...For children, SoE [strength of evidence] was high for no increased risk of autism following measles, mumps, and rubella (MMR)
vaccine. SoE was high for increased risk of febrile seizures with MMR. There was no evidence of increased risk of intussusception with rotavirus vaccine
at the latest follow-up (moderate SoE), nor of diabetes (high SoE). There was no evidence of increased risk or insufficient evidence for key adverse
events for newer vaccines such as 9-valent human papillomavirus and meningococcal B vaccines. For adults, there was no evidence of increased risk
(varied SoE) or insufficient evidence for key adverse events for the new adjuvanted inactivated influenza vaccine and recombinant adjuvanted zoster
vaccine. We found no evidence of increased risk (varied SoE) for key adverse events among pregnant women following tetanus, diphtheria, and acellular
pertussis vaccine, including stillbirth (moderate SoE).
...Across a large body of research we found few associations of vaccines and serious key adverse events; however, rare events are challenging to study.
Any adverse events should be weighed against the protective benefits that vaccines provide.
Back to top
Journal retracts article over
“distorted conclusions” about COVID-19 vaccine safety
On July 2, the editors of the journal Vaccines retracted an article published on June 24 titled “The Safety of COVID-19
Vaccinations—We Should Rethink the Policy.” A portion of the editors’ comments appear below.
...Serious concerns were brought to the attention of the publisher regarding misinterpretation of data, leading to incorrect and distorted
conclusions.
The article was evaluated by the Editor-in-Chief with the support of several Editorial Board Members. They found that the article contained several
errors that fundamentally affect the interpretation of the findings.
These include, but are not limited to:
The data from the Lareb report (https://www.lareb.nl/coronameldingen) in The Netherlands were used to calculate the
number of severe and fatal side effects per 100,000 vaccinations. Unfortunately, in the manuscript by Harald Walach et al. these data were incorrectly
interpreted which led to erroneous conclusions. The data was presented as being causally related to adverse events by the authors. This is inaccurate. In
The Netherlands, healthcare professionals and patients are invited to report suspicions of adverse events that may be associated with vaccination. For this
type of reporting a causal relation between the event and the vaccine is not needed, therefore a reported event that occurred after vaccination is not
necessarily attributable to vaccination. Thus, reporting of a death following vaccination does not imply that this is a vaccine-related event. There are
several other inaccuracies in the paper by Harald Walach et al. one of which is that fatal cases were certified by medical specialists. It should be known
that even this false claim does not imply causation, which the authors imply. Further, the authors have called the events ‘effects’ and
‘reactions’ when this is not established, and until causality is established they are ‘events’ that may or may not be caused by
exposure to a vaccine. It does not matter what statistics one may apply, this is incorrect and misleading.
The authors were asked to respond to the claims, but were not able to do so satisfactorily. The authors were notified of the retraction and did not
agree.
Note that Vaccines is published by MDPI, based in Basel, Switzerland. This is a different publication than the journal Vaccine published by Elsevier, the
multinational publishing house.
Related Links
Back to top
Immunization PSAs from the
Archive
In this engaging
2009 PSA from U.S. Department of Health and Human Services, families of all shapes and sizes can become unraveled from the flu
In this 2009 engaging public service announcement (PSA) from the U.S. Department of Health and Human Services, families of all shapes and sizes
become unraveled when the flu strikes. This PSA is part of a collection curated by vaccine expert William L. Atkinson, MD, MPH, which spans a period of
more than 50 years.
|